E6201, an intravenous MEK1 inhibitor, achieves an...

  • Main
  • 2018 / 9
  • E6201, an intravenous MEK1 inhibitor, achieves an...
Investigational New Drugs 2018 / 9

E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases

Babiker, Hani M., Byron, Sara A., Hendricks, William P. D., Elmquist, William F., Gampa, Gautham, Vondrak, Jessica, Aldrich, Jessica, Cuyugan, Lori, Adkins, Jonathan, De Luca, Valerie, Tibes, Raoul, B
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0668-8
Date:
September, 2018
File:
PDF, 2.39 MB
english, 2018
Conversion to is in progress
Conversion to is failed